Relapsed Neuroblastoma

نویسندگان

  • Brian Weiss
  • John Huberty
  • Katherine K. Matthay
چکیده

Purpose: To describe three patients with secondary leukemia after treatment with I-metaiodobenzylguanidine (MIBG) for neuroblastoma. Methods: Of 95 children with refractory neuroblastoma treated with I-MIBG at UCSF, 3 have been identified with secondary myelodysplasia/leukemia. The case records and bone marrow results were reviewed, along with a review of the literature. Results: Three patients developed secondary myelodysplasia/leukemia, at 7, 11, and 12 months following I-MIBG therapy. Cytogenetic abnormalities included −7q/−5, −7/+2q37, −11 and +12. Three additional cases were found in literature review of 509 reported patients treated with I-MIBG for neuroblastoma. Conclusions: Therapy with I-MIBG may contribute to the risk of secondary leukemia in patients who have received intensive chemotherapy, thought the risk of this complication is far lower than the risk of disease progression. Further monitoring for this complication is indicated.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Palliative effect of I-MIBG in relapsed neuroblastoma after autologous peripheral blood stem cell transplantation

Neuroblastoma accounts for 8-10% of all childhood malignancies. The prognosis of neuroblastoma is highly variable depending on the age at diagnosis, stage of the disease, and tumor biology. High risk is defined as neuroblastoma occurring in children over 1 year of age with an amplification of the MYCN oncogene or distant metastasis 1) . Despite recent improvements in outcome with intensificatio...

متن کامل

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.

Neuroblastoma is an embryonal malignancy that commonly affects young children and is remarkably heterogenous in its malignant potential. Recently, the genetic basis of neuroblastoma has come into focus and not only has catalyzed a more comprehensive understanding of neuroblastoma tumorigenesis but also has revealed novel oncogenic vulnerabilities that are being therapeutically leveraged. Neurob...

متن کامل

Increased Frequency of Aberrations in the p53/MDM2/p14 Pathway in Neuroblastoma Cell Lines Established at Relapse

p53 mutations have been reported in cell lines derived from relapsed neuroblastoma tumors. We hypothesize that functional inactivation of p53 by mutation or other mechanisms is common in relapsed neuroblastoma and can contribute to chemoresistance. Our aim was to determine the frequency of p53 mutations, p14 methylation, or deletion and MDM2 amplification in 23 neuroblastoma cell lines (6 deriv...

متن کامل

Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.

p53 mutations have been reported in cell lines derived from relapsed neuroblastoma tumors. We hypothesize that functional inactivation of p53 by mutation or other mechanisms is common in relapsed neuroblastoma and can contribute to chemoresistance. Our aim was to determine the frequency of p53 mutations, p14(ARF) methylation, or deletion and MDM2 amplification in 23 neuroblastoma cell lines (6 ...

متن کامل

Immune response to racotumomab in a child with relapsed neuroblastoma

Immunotherapy targeting ganglioside antigens is a powerful tool for the treatment of high risk neuroblastoma. However, only treatment with anti-GD2 antibodies has been used in clinical practice and other options may be pursued. We report the use of racotumomab, an anti-idiotype vaccine against N-glycolyl neuraminic acid (NeuGc)- containing gangliosides, eliciting an immune response in a child w...

متن کامل

Overview and recent advances in the treatment of neuroblastoma.

INTRODUCTION Children with neuroblastoma have widely divergent outcomes, ranging from cure in >90% of patients with low risk disease to <50% for those with high risk disease. Recent research has shed light on the biology of neuroblastoma, allowing for more accurate risk stratification and treatment reduction in many cases, although newer treatment strategies for children with high-risk and rela...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2003